Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein maestro (MRO) is a human gene located on chromosome 18 (18q21.1), with gene synonyms including B29, C18orf3, and FLJ30140[1][2]. The protein’s full biological function remains unclear, but limited data suggest MRO is specifically expressed during male reproductive organ development and may be involved in sex-specific transcriptional regulation. It does not belong to major therapeutic target classes such as receptors, enzymes, ion channels, or transporters, and there is no evidence it serves as a common drug target or clinical biomarker[1][2]. There are currently no described roles in cancer, inflammation, or other common disease categories, though it appears on broad lists of genes of interest. No drugs are known to interact with Protein maestro[3], and no mechanism of action or notable safety concerns have been described in the literature as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein maestro (MRO).